COVID-19 epidemiology in rheumatic diseases in Tuscany: A case-control study

Joint Bone Spine. 2021 May;88(3):105131. doi: 10.1016/j.jbspin.2021.105131. Epub 2021 Jan 21.

Authors

Paolo Francesconi¹, Fabrizio Cantini², Francesco Profili¹, Alessandro Mannoni³, Benedetta Bellini¹, Maurizio Benucci⁴

Affiliations

¹ Regional health agency of Tuscany epidemiology observatory, Florence, Italy.
² Department of rheumatology, Azienda USL Toscana centro, Hospital of Prato, Prato, Italy.
³ Rheumatology unit, Hospital P. Palagi, Azienda USL - Toscana centro, Florence, Italy.
⁴ Rheumatology unit, S. Giovanni di Dio Hospital, Azienda USL - Toscana Centro, Via Torregalli 3, 50143 Florence, Italy. Electronic address: maubenucci@tiscali.it.

No abstract available

Keywords: B-DMARDs; COVID-19; Rheumatic disease.

Publication types

Letter

MeSH terms

Antirheumatic Agents* / therapeutic use
COVID-19*
Case-Control Studies
Humans
Rheumatic Diseases* / diagnosis
Rheumatic Diseases* / drug therapy
Rheumatic Diseases* / epidemiology
SARS-CoV-2

Substances

Antirheumatic Agents